Close Menu


Wyss has nearly 200 researchers and support staffers engaged in projects led by 16 core faculty members and a group of associated faculty drawn from several Harvard schools and affiliated institutions.

Under the multiple-year agreement, Agilent Technologies agreed to offer the Wyss Institute for Biologically Inspired Engineering at Harvard University an undisclosed amount of "financial support," as well as technical expertise, and tools and materials.

In the study, out of three patients with ALK gene rearrangements, two responded partially to Infinity's investigational drug IPI-504, and one experienced prolonged stable disease while on the treatment for 7.2 months and had a 24 percent reduction in tumor size.

The Personal Genome Project, which will enroll 1,000 additional participants this month, plans to make more genome data from participants publicly available by the end of November, including complete genomes of the first 10 participants, known as the PGP-10, and four additional genomes from "recent enrollees."

Golden Helix is working with Harvard to rewrite the code for an informatics tool for studying disease heritability in families.

IP Roundup: Sep 7, 2010


Samsung Electronics, Sungkyunkwan University, Novartis Vaccines and Diagnostics, Stanford University, Harvard University, Baltic Technology Development, University of Maryland, Cyclops Genome Sciences, Universite de Geneve, SRU Biosystems, Austrian Research Centers of Vienna, Tecnet Capital Technologiemanagement, Illumina, Fluidigm

Roche, Harvard University, Gen-Probe, U of Arkansas, Samsung, Quest, Eyetech, Novartis, Idaho Tech, University of Utah, and Mayo Clinic awarded US patents.

GnuBio, founded on technology developed by Harvard's David Weitz, aims to develop a scalable DNA sequencer that can analyze a human genome at 30-fold coverage for less than $100 in sequencing reagent costs, and small candidate gene regions at 100-fold coverage for less than $2 per sample.

Two new studies describe how researchers used a meta-analysis of genome-wide association study data as the basis for functional experiments on the genetics of blood lipid levels and heart disease risk.

A single molecule imaging study suggests the levels of messenger RNA and protein produced from the same gene do not correlate with one another in individual Escherichia coli cells.


UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.